Mr Alan Doherty is a highly specialised consultant urologist with privates clinics at Spire Parkway Hospital, Nuffield Health Warwickshire Hospital, BMI The Priory Hospital and Spire Little Aston. He specialises in state of the art diagnostics, nerve sparing open radical prostatectomy, greenlight laser prostate surgery, template mapping biopsies, radical cystectomy, Rezum and UroLift.
Mr Doherty is a highly specialized full time consultant urologist qualified in London, before moving to Birmingham where he specialised in prostate diseases. He trained at The Middlesex Hospital, the Royal Marsden, Charing Cross Hospitals and the Institute of Urology before taking up his position as a consultant urologist at Queen Elizabeth Hospital Birmingham in 2001.
He has been a consultant urologist for 20 years, working in one of the biggest cancer centres in the UK. He has performed nearly 4000 prostatectomies and specialises in nerve-sparing to preserve erectile function. He has a track record of being able to maintain potency in up to 80% of his patients. When it comes to diagnosing prostate cancer, Mr Doherty uses PSA, MRI tests, PSMA PET scans and the urinary PCA3 gene test to avoid prostate biopsies if possible. He provides an MRI fusion mapping template prostate biopsy service. He has recently joined the focal therapy group to deliver HIFU to select cases of prostate cancer.
Mr Doherty recently resigned from the University Hospital Birmingham NHS Trust, Queen Elizabeth Hospital. He is one of the first surgeons in the UK to perform laparoscopic cystectomy (bladder removal) and laparoscopic nephrectomy (kidney removal) and prostatectomy. He has also performed over 1000 GreenLight laser procedures and is a national trainer in the technique. He is one of a small number of surgeons using the ‘third generation’ XPS laser technology.
He has published extensive results from his nerve-sparing procedures. He was voted on two occasions one of the UK’s top ten prostate cancer specialists in a national poll of consultant urologists published in the Daily Mail. He also led the development of a live prostate cancer results centre allowing patients to track their individual recovery and compare outcomes which had him shortlisted for a prestigious Health Service Journal award.